ToxSci Advance Access originally published online on February 16, 2006
Toxicological Sciences 2006 91(1):309; doi:10.1093/toxsci/kfj134
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Communication Regarding Metabonomic Identification of Two Distinct Phenotypes in Sprague-Dawley (Crl:CD(SD)) Rats

* Pfizer Global Research and Development, Metabonomics Evaluation Group, Ann Arbor, Michigan 48105;
Manpower, Inc., Ann Arbor, Michigan 48103
1 To whom correspondence should be addressed at Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105. Fax: (734) 622-2716. E-mail: lora.robosky@pfizer.com.
Received October 9, 2005; accepted January 27, 2006
| The first 10% of the full text of this article appears below. |
In a recent publication, we reported the identification and characterization of two distinct phenotypes in Sprague-Dawley rats obtained from the Charles River Raleigh facility (Robosky et al., 2005
). The phenotypes were designated as HIP (high hippuric acid level in urine) and CA (high chlorogenic